Related Experiment Video
Updated: Mar 9, 2026

09:59
Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
26.2K
Exosomes: Nanoparticulate tools for RNA interference and drug delivery
Fahimeh Shahabipour1, Nastaran Barati2, Thomas P Johnston3
1National Cell Bank of Iran, Pasteur Institute of Iran, Tehran, Iran.
Journal of Cellular Physiology
|January 8, 2017
Summary
Exosomes, tiny vesicles from cells, are emerging as powerful tools for delivering drugs and therapeutic RNA molecules. Their natural properties offer advantages for cell-cell communication and targeted delivery in medicine.
Area of Science:
- Biochemistry
- Cell Biology
- Nanotechnology
Background:
- Exosomes are extracellular vesicles involved in intercellular communication.
- They carry lipids, proteins, and RNA, making them potential disease biomarkers.
- Exosomes offer advantages over conventional delivery systems for therapeutic applications.
Purpose of the Study:
- To review recent advancements in using exosomes for drug delivery.
- To highlight the potential of exosomes in delivering therapeutic RNA molecules.
- To discuss current trends and future prospects of exosome-based delivery systems.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of studies focusing on exosome biogenesis and cargo.
- Evaluation of exosome-based drug and RNA delivery strategies.
Main Results:
- Exosomes facilitate the transfer of genetic and biochemical information.
- They show promise for delivering therapeutic proteins, microRNAs, and small interfering RNAs.
- Exosomes can overcome challenges like RNA degradation and inefficient tissue targeting.
Conclusions:
- Exosomes represent a novel and effective platform for drug and gene delivery.
- Further research into exosome engineering can enhance their therapeutic potential.
- Exosomes are poised to revolutionize targeted therapies and disease management.
Related Concept Videos
Overview of Exosomes
3.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.8K
siRNA - Small Interfering RNAs
18.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.9K
Experimental RNAi
8.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.1K
RNA Interference
28.4K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.4K
Small interfering RNAs (siRNA)
5.1K
5.1K
MicroRNAs
4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K

